Advocate for Change

Advocate for policy

Fighting for more resources and new public policies to improve quality of life for all those affected

Ensuring better patient access to essential health care is critical to the needs of our community. Working alongside regulators and policymakers, we believe education is key to improving the lives of all those affected by brain tumors, and essential for change.

Take action now

TAKE ACTION NOW

Let your voice be heard - join us and take action on critical issues affecting the brain tumor community today.

Advocate tools and training

Advocacy tools

Become more informed about key public policy issues and learn how to educate your elected officials.

Latest news

Latest Public Policy News

Stay up to date on the latest in brain tumor research funding, access to care, and advocacy efforts across the community.

From the Blog

  1. October 22, 2014

    Hope for GBM Patients

    Recent news and conversations across social media has churned up a lot of concern and fear over glioblastoma multiforme (GBM) tumors. And while we know all too well it’s the deadliest form of brain cancer with dismal survival rates, we also want the public to know how the National Brain Tumor Society is working to […]

    Hope for GBM Patients Read more | 
  2. October 10, 2014

    Advocating for Childhood Cancer Cures

    National Brain Tumor Society is driven to create change for the more than 4,000 children and their families who will receive the terrible diagnosis of a pediatric brain tumor this year. In addition to our funded initiatives, we also are committed to working with the greater pediatric cancer community to help advance research toward new […]

    Advocating for Childhood Cancer Cures Read more | 
  3. October 9, 2014

    National Brain Tumor Society 2014 Summit Reviews Systemic Change Happening in Brain Cancer Research & Development, Honors Community Leaders

    National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, hosted its 2014 Summit and Annual Meeting in Cambridge, MA, on October 1-2. The yearly event brought together a cross-section of the brain tumor community, including neuro-oncologists, medical academics, biotechnology and pharmaceutical executives, representatives from the National Institutes […]

    Read more | 
More from the blog